MicroRNAs (miRNAs) play important roles in post-transcriptional gene silencing of target messenger RNAs, which are involved in virtually all biological processes. Previously, we have demonstrated that spheroid bodyforming cells from the MKN-45 cancer cell line possessed gastric cancer stem cell (CSC) properties. In this study, we aimed to determine the miRNA profile of the gastric CSCs and to explore the role of miRNAs in gastric CSCs. Human miRNA microarrays, which contain probes specific for 1887 human miRNAs were used to determine the expression profiles of the gastric CSCs. A total of 182 miRNAs with a more than 2-fold change were identified to be differentially expressed between the spheroid bodyforming cells and the parental cells. Of these miRNAs, 9 miRNAs were over-expressed in the spheroid bodyforming cells, while the other 173 miRNAs were all under-expressed, indicating that the role of most miRNAs in human gastric CSCs may be tumor suppressors. The results of microarray analysis were validated by quantitative real-time polymerase chain reaction, and the consistence rate is 70% (7 out of 10). The target genes for the validated miRNAs were predicted by using three online software programs, miRanda, PicTar, and TargetScan. Most of the potential targets of the miRNAs were relevant to the regulation of actin cytoskeleton, focal adhesion, extracellular matrix -receptor interaction, and the pathways in cancer. Especially, several genes are associated with some pivotal signaling pathways of the 'stem cell genes'. Evaluating the characteristic miRNAs of the gastric CSCs may be a new method for studying gastric cancer and developing therapeutic strategies, which aimed at eradicating the subpopulation of CSCs in gastric cancer.
Introduction
Gastric cancer is the second commonest cancer worldwide and the second commonest cause of cancer-related death [1] . Despite the overall decline in the prevalence of gastric cancer, the treatment of gastric cancer still remains a challenging problem. Surgical resection remains the primary curative modality. However, the results are often disappointing, with recurrence rates as high as 70% after successful complete (R0) resection [2] . Trials of post-operative chemoradiation or perioperative chemotherapy report only a 10%-15% absolute reduction in the risk of recurrence [3, 4] . Overall, the advancement in survival of gastric cancer patients in the past few decades was relatively small, with a 5-year survival rate of about 28% [1] , due to a lack of deep understanding of the molecular mechanism of gastric cancer.
Recently, the cancer stem cell (CSC) theory hypothesizes that only the rare subpopulation of tumor cells, termed CSCs, are regarded as the cause of tumor formation, recurrence, metastasis, and resistance to traditional therapy [5] . This new paradigm has remarkable implications for cancer therapy because it suggests that our current therapies are more successful in eradicating non-CSCs than CSCs [6, 7] . Research focusing on CSCs is likely to bring revolutionary changes to our understanding of gastric cancer. Some studies have been conducted to investigate the stemness genes and their products that participate in the stemness maintenance and tumorigenicity of CSCs [8, 9] . However, the underlying mechanisms of how intrinsic CSC properties are regulated at the molecular level remain largely unknown.
MicroRNAs (miRNAs) are short (19-24 nt) non-coding RNAs (RNAs that do not encode proteins) that play important roles in post-transcriptional gene silencing of target messenger RNAs (mRNAs) [10] . Emerging evidence has demonstrated that numerous miRNAs participated in several biological functions, including cellular proliferation [11] , differentiation [12] , and apoptosis [13] . Recent studies have shown that the miRNAs are also involved in the function of
human CSCs. For example, Let-7 was considered to be responsible for breast CSCs (BCSCs) properties including self-renewal and multipotent differentiation potential [14] . In glioblastoma, the aberrant cellular proliferation and selfrenewal were associated with decreased expression of miR-128, which targeted Bmi-1 [15] . Over-expression of miR-320 in prostate cancer (PCa) cells decreased PCa tumorigenesis in vitro and in vivo, which indicated that miR-320 is a key negative regulator in prostate CSCs [16] . In hepatocellular carcinoma, EpCAM þ AFP þ CSCs expressed a unique miRNA signature with up-regulation of miR-181 family members and several miR-17-92 cluster members [17] . However, the role of the miRNAs in human gastric CSCs is still unknown, and the miRNA profile of the gastric CSCs has never been evaluated. In this study, we aimed to determine the miRNA profile of the gastric CSCs in the MKN-45 cancer cell line and to explore the role of the miRNAs in gastric CSCs.
Materials and Methods
The parental cell and spheroid body-forming cell culture Human gastric cancer cell line MKN-45 was purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China), and cultured in 1640 medium containing 10% fetal bovine serum and plated at a density of 1 Â 10 6 live cells per 75 cm 2 flask. After the cells attached, they were subsequently passaged upon confluence. Spheroid bodies were derived by placing the parental cells into serumfree 1640 culture medium containing 1% N-2 supplement (Invitrogen, Carlsbad, USA), 2% B-27 supplement (Invitrogen), 1% antibiotic mixture (Gibco, Carlsbad, USA), 20 ng/ml human FGF-2 (Chemicon, Temecula, USA), and 100 ng/ml epidermal growth factor (EGF) (Chemicon). The parental cells were plated in 96-well ultra-low attachment plate (Corning Inc., Corning, USA) at 100 cells per well. Two weeks later, the plates were analyzed for spheroid body formation and were quantified by using an inverted microscope (Olympus, Tokyo, Japan) at Â40 and Â100 magnification. When the primary spheroid body reached the size of 200-500 cells per spheroid body, the spheroid bodies were dissociated at a density of 1000 cells per ml, and then 100 single cell suspension (100 ml) was seeded in each well of the 96-well ultra-low attachment plate (Corning) in serumfree medium, as described previously. Two weeks later, the wells were analyzed for sub-spheroid body formation.
miRNA extraction and reverse transcription Total RNA, including the miRNAs, was extracted from the spheroid body-forming cells and the MKN-45 parental cells, and purified by using the miRNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The RNA concentration was quantified by using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Waltham, USA). The integrity and the quality of RNA were evaluated by Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, USA). RNAs with a 2100RIN (RNA integrity number) !6.0 and 28S/18S !0.7 were used for the miRNA array analysis and reverse transcription (RT). An aliquot of 1.0 mg of total RNA was converted to cDNA by using the miScript II RT kit (Qiagen).
miRNA array assay Qualified RNA samples were further detected by the miRNA array at Shanghai Biochip, Co., Ltd. (Shanghai, China), by using Agilent's human miRNA microarray, version 18.0, which contains 1887 human and 89 human viral miRNA sequences from the Sanger v18.0 miRNA database. Labeling and hybridization were performed according to the manufacturer's protocols. Signals on the slides were scanned by using an Agilent G2565BA microarray scanner.
Quantitative real-time polymerase chain reaction analysis Quantitative real-time polymerase chain reaction (qRT-PCR) was performed by using the miScript SYBR Green PCR kit (Qiagen) according to the manufacturer's instructions on an LC480 II RT-PCR platform (Roche, Indianapolis, USA). A universal reverse primer was provided by the manufacturer, and each forward primer was specific to the mature miRNA listed in the Sanger miRNA database. The expression of the miRNAs was normalized by using U6 small RNA as the endogenous control. The analyzed miRNAs included: miR-181a-5p, miR-27a-3p, miR-34a-5p, miR-21-5p, miR-483-5p, miR-22-3p, miR-4270, miR-16-5p, let-7b-3p, and miR-29a-3p. The experiments were repeated three times independently.
Bioinformatics analysis and target prediction
Three online software programs, miRanda http://microrna. sanger.ac.uk, PicTar http://www.ncrna.org/KnowledgeBase/ link-Database/mirna_target_database, and TargetScan http:// www.targetscan.org, were used for bioinformatics analysis and target prediction for the qRT-PCR validated miRNAs.
Results
Gastric cancer cells could form anchorage-independent spheroid bodies MKN-45 parental cells were cultured in serum-free medium as described in the Methods section. In this condition, the cells grew as non-adherent, 3D spheroid clusters, called spheroid body. The self-renewing capacity of these spheroid body-forming cells was assessed by dissociating into single cell and growing in serum-free medium as described in the Methods section. Figure 1 showed the different spheroid body-forming capacities between the spheroid body-forming miRNA expression profiles in spheroid body-forming cells relative to parental cells We used an miRNA microarray to evaluate the miRNA expression profiles in the spheroid body-forming cells and the parental cells. The miRNA expression pattern was found to be significantly different. A total of 182 miRNAs with a more than 2-fold change were differentially expressed between the spheroid body-forming cells and the parental cells ( Table 1) . Of these miRNAs, nine were over-expressed in the spheroid body-forming cells, with white font and black shade in Table 1 , while the others (173) were all under-expressed.
Validation of differentially expressed miRNAs by qRT-PCR
We performed qRT-PCR for 10 miRNAs: miR-181a-5p, miR-27a-3p, miR-34a-5p, miR-21-5p, miR-483-5p, miR-22-3p, miR-4270, miR-16-5p, let-7b-3p, and miR-29a-3p. The qRT-PCR results for the 10 tested miRNAs were 0.49 + 0.05, 0.81 + 0.14, 2.57 + 0.07, 0.74 + 0.05, 2.63 + 0.31, 0.68 + 0.28, 1.61 + 0.08, 1.64 + 0.14, 1.18 + 0.07, and 0.44 + 0.03 (expressed as the relative ratio between the spheroid body-forming cells and the parental cells + standard deviation). Seven of the 10 tested miRNAs gave qRT-PCR results that were concordant with the microarray data (Fig. 2) , with miR-16-5p, let-7b-3p, and miR-34a-5p being the exceptions, indicating a concordance rate of 70.0%.
Bioinformatics analysis and preliminary functional analysis of the spheroid body-forming cells related miRNAs Target prediction of the miRNAs was carried out by using three online software programs, miRanda, PicTar, and TargetScan. To increase the specificity (at the cost of lower sensitivity), we integrated the results of three target prediction programs and examined only the intersection. We found that 384 miRNA : mRNA target pairs were predicted by all of the three programs (Fig. 3) . Among the 10 qRT-PCR validated miRNAs, miR-181a-5p, miR-27a-3p, miR-34a-5p, miR-21-5p, miR-22-3p, miR-4270, let-7b-3p, and miR-29a-3p have predicted targets, while there were no predicted targets for miR-483-5p and miR-16-5p.
We ranked the miRNA -target gene interactions and generated a network by using CytoScape w to visualize the predicted miRNA -mRNA interactions (Fig. 4) . There were more than ten to hundreds of predicted target genes for each miRNA. Several genes were identified as the potential targets of two or more of the miRNAs. For example, two genes (LGR4 and OSGIN2) were the predicted targets of miR-34a-5p and let-7b-3p. PLAG 1 was the predicted target of miR-34a-5p, miR-181a-5p, let-7b-3p, and miR-21-5p. ZMYM4 was the predicted target of miR-29a-3p, miR-22-3p, miR-21-5p, let-7b-3p, and miR-34a-5p. Most of these targets were relevant to the regulation of actin cytoskeleton, focal adhesion, extracellular matrix -receptor interaction, and the pathways in cancer. Especially, several genes were associated with some pivotal signaling pathways of the 'stem cell genes', such as Notch, Wnt/b-catenin, mitogen-activated protein kinase (MAPK), mammalian target of rapamycin (mTOR), and Janus kinase/signal transducer and activator of transcription (JAK-STAT), etc. ( Table 2 ).
Discussion
Because the specific makers for most of the CSCs have not been defined, the spheroid body formation assay, in which the cells are cultured in non-adherent condition in a serum-free medium supplemented with basic fibroblast growth factor and EGF, is a practical approach for the isolation of CSC from solid tumors or cancer cells [18, 19] . Previously, we demonstrated that non-adherent spheroid body-forming cells from the gastric cancer cell line MKN-45 cultured in stem cellconditioned medium possessed gastric CSC properties, hsa-miR-196a-5p hsa-miR-4665-3p hsa-miR-5001-5p hsa-miR-4730 hsa-miR-15b-5p hsa-miR-3614-5p hsa-miR-23b-3p hsa-miR-1249 hsa-miR-4741 hsa-miR-3180-5p hsa-miR-1260a hsa-miR-4299 hsa-miR-1225-3p hsa-miR-197-3p hsa-miR-4485 hsa-miR-320c hsa-miR-3651 hsa-miR-30d-5p hsa-miR-4466 hsa-miR-4739 hsa-miR-3675-3p hsa-miR-4749-3p hsa-miR-365a-3p hsa-miR-4646-3p
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Nine miRNAs with white font and black shade were over-expressed in the spheroid body-forming cells.
MicroRNA expression profile of gastric cancer stem cells
In the present study, we obtained the miRNA expression profiles of the gastric CSCs, providing a substantial basis for exploring the role of the miRNAs in maintaining the stem cell properties and the biological functions of the gastric CSCs. We found that a total of 182 miRNAs with a more than 2-fold change were differentially expressed between the spheroid body-forming cells and the parental cells, and most of them (173) showed very low-level expression in the spheroid body-forming cells, which were increased upon differentiation, indicating that the role of most of the miRNAs in human gastric CSCs may be of tumor suppressors.
In order to confirm the results obtained from the miRNA microarray, the expressions of miR-29a-3p, miR-181a-5p, miR-21-5p, miR-16-5p, miR-27a-3p, miR-22-3p, let-7b-3p, miR-34a-5p, miR-4270, and miR-483-5p were analyzed by qRT-PCR. Seven of 10 miRNAs tested were consistent with the results from the miRNA microarrays, with miR-16-5p, let-7b-3p, and miR-34a-5p being the exception, indicating a concordance rate of 70.0%. Five miRNAs, miR-29a-3p, miR-181a-5p, miR-21-5p, miR-27a-3p, and miR-22-3p were down-regulated in the spheroid body-forming cells, while let-7b-3p, miR-16-5p, miR-34a-5p, miR-4270, and miR-483-5p were up-regulated, compared with the parental cells (P 0.05). Some of these significantly changed miRNAs, such as miR-21-5p, miR-29a-3p, and let-7b-3p, etc. have been found to take part in a number of biological functions such as tumor formation, differentiation, and proliferation. Cittelly et al. [21] demonstrated that the downregulation of miR-29 members potentiated the expansion of the tumor-initiating marker CD442 and the progenitor marker cytokeratin 5 (CK5)-positive cells in response to the progestins, and resulted in increased stem-like properties in vitro and in vivo. They also demonstrated that miR-29 directly targeted Krüppel-like factor 4 (KLF4), a transcription factor required for the reprogramming of differentiated cells to pluripotent stem cells, and for the maintenance of BCSCs. Zhou et al. [22] reported that the higher expression of miR-21 was observed in the side population cells, which possessed stem cell-like properties. The silencing of miR-21 led to a reduction in the migration and invasion of these cells and the over-expression of miR-21 can increase cell migration and invasion. However, Sun et al. [23] reported that miR-21 expression was lower in BCSCs than in MCF-7 cells. In our study, the expression level of miR-21 in the spheroid body-forming cells of human gastric cancer cell line MKN-45 was also decreased. The inconsistencies between these studies require further analysis. However, the possibility that the miRNAs were deregulated remains in gastric CSCs.
MicroRNAs are involved in the regulation of protein expression primarily by binding to one or more target sites on an mRNA transcript and inhibiting translation. A key factor for inferring the function of the miRNAs is through their target genes. Thus, the identification of target mRNAs is of utmost importance in understanding the miRNA function. Bioinformatics analysis and prediction programs are the primary methods which are used to explore the function of the miRNAs [24] . Because the current sequencebased available target prediction algorithms are known to have high false-positive rates, and their predictions are not in agreement [25] , we intersect the results of the three prediction algorithms in order to obtain more confident target genes for each miRNA. In our study, we found that there were more than ten to hundreds of target genes for each miRNA. Among these target genes, several genes are associated with some pivotal signaling pathways of the 'stem cell genes', such as Notch, Wnt/b-catenin, MAPK, mTOR, and JAK-STAT, etc. For example, the targets of miR-34a-5p are NOTCH1, FOSL1, and LEF1, which may be related to the Notch and the Wnt signaling pathways, and the target of miR-29a is PTEN, which may be related to the mTOR signaling pathways. As for miR-21a, the target is SPRY1, which may be related to the JAK-STAT signaling pathways. It has been reported that these miRNAs target the 'stem cell genes' involved in the self-renewal and survival of the CSCs. Ji et al. [26] demonstrated that miR-34 might be involved in pancreatic CSC self-renewal and/or cell fate determination, potentially via the direct modulation of downstream targets Bcl-2 and Notch. Tumaneng et al. [27] reported that YAP (Yes-associated protein), the main downstream target of the mammalian Hippo pathway, downregulated PTEN by inducing miR-29 to inhibit PTEN translation, an upstream negative regulator of mTOR. Ma et al. [28] found that a large number of validated or predicted miR-21 target genes, specifically, SPRY1, PTEN, and PDCD4 were up-regulated in miR-21-null keratinocytes, which are the precursor cells to skin papillomas. All of these examples suggest that the miRNAs play a pivotal role in carcinogenesis and oncogenesis by regulating self-renewal and the CSC signaling pathways as oncogenes or tumor suppressors, respectively, although some interactions of miR-mRNA have not been discerned. Further work should be performed to determine whether these genes are the authentic targets of all of the miRNAs identified here.
In summary, we investigated the miRNA expression profile of the gastric CSC subpopulation from the MKN-45 cell line for the first time. Our results suggested that the miRNAs might play important roles in maintaining the stemness of the gastric CSCs. The identification of the miRNA profiles will excite a new insight into the molecular mechanism for elucidating the characters of the gastric CSCs, which may help cancer biologists and clinical oncologists in designing and testing novel therapeutic strategies.
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